Angle’s Andrew Newland talks to EPM about the high level of interest from across the globe in the company’s cell separation technology, Parsortix, which captures cancer cells circulating in the blood — even if they are as few as one in one billion — and harvests those cells for analysis
Angle’s Andrew Newland